Weight Loss

SATIN chief: “...even if not combined with another effective mono-therapy it could become a very powerful tool.”

"We hope to develop a pill for fexaramine within 24 to 36 months to try in humans."

Satiety pill shows metabolic syndrome potential: Mice study

By Shane STARLING

The mainstream press has latched onto a mouse study that shows a bile-controlling, gut restricted pharma intervention can mimic food intake and therefore potentially be an obesity beater. But could it pass clinical inspection? One weight loss researcher...

Spotlight

Follow us

Products

View more

Webinars

Food & Beverage Trailblazers Podcast

F&B Trailblazers Podcast

Featured Suppliers

All suppliers